Nuwellis Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Direxion Daily TSLA Bull 2X Shares trades at $11.26. Which is the better fit depends on your goals.
| NUWE | TSLL | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $527.46 | $23.03 |
52-Week Low | $2.80 | $10.29 |
Enterprise Value | -$722.58K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TSLL is trading at $10.72, down 5.84% over the past day, with a bearish technical signal from moving averages and neutral oscillators. Key support lies at $10 and resistance at $11. The company has announced a future dividend of $0.10 per share scheduled for June 30, 2026. Recent news highlights focus on Tesla's upcoming earnings and related ETF movements, which may influence TSLL's performance given its thematic exposure.
The outlook for TSLL is cautious due to bearish technical indicators and reliance on Tesla's earnings catalyst. Investment opportunities hinge on positive earnings surprises from Tesla boosting the ETF, while risks include continued technical weakness and broader market volatility affecting leveraged ETF performance.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →